PubMed laboratory research record [PMID: 41937527] PubMed record related to this compound for laboratory literature review
Understanding these common reactions helps patients distinguish between expected, manageable symptoms and those requiring medical attention
Even as new research and approvals by the U.S
The most frequent gastrointestinal side effects include: Nausea and vomiting : Very common, typically most pronounced during dose escalation Diarrhoea : Common to very common, though usually mild to moderate Constipation : Can occur due to delayed gastric emptying and reduced gut motility Abdominal pain and discomfort : Common Dyspepsia and gastro-oesophageal reflux : May worsen in susceptible individuals Other important adverse effects include: Gallbladder disorders : Cholelithiasis and cholecystitis have been reported, particularly with weight loss Dehydration and acute kidney injury : May occur secondary to severe gastrointestinal symptoms Hypoglycaemia : Risk increases when used with insulin or sulfonylureas, which may require dose adjustment Current limited evidence does not suggest an increased risk of inflammatory bowel disease (IBD) flares with GLP-1 agonists, though more data are needed
Consistent weekly use as prescribed by your doctor is key to achieving the best results
Both HSA and FSA cards are accepted, along with major credit cards